IP Library Assignment 065610/0460
Patent Assignment
Reel/Frame 065610/0460

Release of Patent Security Interests Recorded at Reel 044949, Frame 0634

Recorded: 2023-11-16 Pages: 43
Assignor
Assignees
MALLINCKRODT INTERNATIONAL FINANCE S.A.
124 BOULEVARD DE LA PETRUSSE, L-2330 LUXEMBOURG, LUXEMBOURG
MALLINCKRODT CB LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 93042
MALLINCKRODT FINANCE GMBH
VICTOR VON BRUNS-STRASSE 19, 8212 NEUHAUSEN AM RHEINFALL, SWITZERLAND
MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT CARRIBEAN, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT US POOL LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MNK 2011 LLC (F/K/A MALLINCKRODT INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
LUDLOW LLC (F/K/A LUDLOW CORPORATION)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
CNS THERAPEUTICS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT ENTERPRISES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
LAFAYETTE PHARMACEUTICALS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
LIEBEL-FLARSHEIM COMPANY LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT VETERINARY, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT US HOLDINGS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
IMC EXPLORATION COMPANY
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MEH, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
SPECGX LLC
385 MARSHALL AVENUE, WEBSTER GROVES, MISSOURI, 63119
STRATATECH CORPORATION
510 CHARMANY DR. NO. 169, MADISON, WISCONSIN, 53719
SUCAMPO PHARMA AMERICAS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
VTESSE LLC (F/K/A VTESSE INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
INFACARE PHARMACEUTICAL CORPORATION
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
ST SHARED SERVICES LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
THERAKOS, INC.
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
IKARIA THERAPEUTICS LLC
53 FRONTAGE ROAD, THIRD FLOOR, HAMPTON, NEW JERSEY, 08827
INO THERAPEUTICS LLC
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
Covered Properties (37)
Bending Device for Hollow Double-Structured Pipe
Patent: 5,749,255 →
Application: 08/761,829 →
Trailer Landing Gear Device
Patent: 6,010,154 →
Application: 08/940,757 →
Aluminosilicate Glass for Flat Display Device
Patent: 6,087,284 →
Application: 09/084,252 →
Optically Amplifying Device with Gain Equalizing Function
Patent: 6,144,488 →
Application: 09/265,556 →
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent: 7,169,899 →
Application: 09/679,331 →
Macrocyclic Antagonists of the Motilin Receptor
Patent: 7,521,420 →
Application: 10/872,142 →
Publication: US 2005/0054562
Spatially-Defined Macrocycles Incorporating Peptide Bond Surrogates
Patent: 7,550,431 →
Application: 10/911,219 →
Publication: US 2005/0119169
Conformationally-Controlled Biologically Active Macrocyclic Small Molecules as Motilin Antagonists or Ghrelin Agonists
Patent: 7,452,862 →
Application: 10/911,221 →
Publication: US 2005/0137127
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent: 8,188,216 →
Application: 10/961,856 →
Publication: US 2005/0049234
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Patent: 7,491,695 →
Application: 11/149,512 →
Publication: US 2007/0021331
Macrocyclic Modulators of the Ghrelin Receptor
Patent: 7,476,653 →
Application: 11/149,731 →
Publication: US 2006/0025566
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent: 8,008,440 →
Application: 11/615,332 →
Publication: US 2007/0117154
Methods of Using Macrocyclic Agonists of the Ghrelin Receptor for Treatment of Gastrointestinal Motility Disorders
Patent: 8,088,733 →
Application: 11/774,185 →
Publication: US 2008/0051383
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Patent: 9,371,297 →
Application: 12/028,611 →
Publication: US 2008/0194672
Spatially-Defined Macrocyclic Compounds Useful for Drug Discovery
Patent: 8,022,252 →
Application: 12/197,610 →
Publication: US 2009/0137817
Intermediates for Macrocyclic Compounds
Patent: 9,181,298 →
Application: 12/273,638 →
Publication: US 2009/0240027
Processes for Intermediates for Macrocyclic Compounds
Patent: 8,129,561 →
Application: 12/273,648 →
Publication: US 2009/0137835
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Patent: 8,450,268 →
Application: 12/333,026 →
Publication: US 2009/0170757
Pharmaceutical Salts of Macrocyclic Modulators of the Ghrelin Receptor
Patent: 8,334,256 →
Application: 12/351,395 →
Publication: US 2009/0221689
Macrocyclic Antagonists of the Motilin Receptor for Treatment of Gastrointestinal Dysmotility Disorders
Patent: 9,133,235 →
Application: 12/440,802 →
Publication: US 2010/0093720
Spatially-Defined Macrocycles Incorporating Peptide Bond Surrogates
Patent: 8,557,765 →
Application: 12/471,978 →
Publication: US 2009/0312540
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Patent: 42,624 →
Application: 12/635,871 →
Macrocyclic Modulators of the Ghrelin Receptor
Patent: 42,013 →
Application: 12/636,048 →
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,173,706 →
Application: 12/753,763 →
Publication: US 2010/0280119
Spatially-Defined Macrocyclic Compounds Useful for Drug Discovery
Patent: 8,440,851 →
Application: 13/036,204 →
Publication: US 2011/0237785
Processes for Intermediates for Macrocyclic Compounds
Patent: 8,497,242 →
Application: 13/036,484 →
Publication: US 2011/0245459
Methods of Using Macrocyclic Modulators of the Ghrelin Receptor
Patent: 8,349,887 →
Application: 13/173,929 →
Publication: US 2011/0288163
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent: 9,018,419 →
Application: 13/218,784 →
Publication: US 2012/0046441
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,492,439 →
Application: 13/436,642 →
Publication: US 2012/0208885
Macrocyclic Modulators of the Ghrelin Receptor
Patent: 8,921,521 →
Application: 13/716,748 →
Publication: US 2013/0211045
Methods of Making L-Ornithine Phenyl Acetate
Patent: 8,946,473 →
Application: 13/878,146 →
Publication: US 2013/0211135
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,785,498 →
Application: 13/937,107 →
Publication: US 2013/0296429
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 9,034,925 →
Application: 14/299,940 →
Publication: US 2014/0288327
Macrocyclic Modulators of the Ghrelin Receptor
Patent: 9,493,505 →
Application: 14/530,311 →
Publication: US 2015/0148290
Methods of Making L-Ornithine Phenyl Acetate
Patent: 9,260,379 →
Application: 14/601,591 →
Publication: US 2015/0133684
Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
Patent: 9,409,945 →
Application: 14/696,742 →
Publication: US 2015/0315235
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 9,604,909 →
Application: 14/715,481 →
Publication: US 2015/0251990
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 26, 2017
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 041097/0984 →
Terms and Conditions of Employment Jan 26, 2017
From: DOUGAN, CHRISTINE
To: SOLID FORM SOLUTIONS LIMITED
Reel/Frame 041513/0173 →
Assignment of Assignor's Interest Jan 26, 2017
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0073 →
Assignment of Assignor's Interest Jan 26, 2017
From: WATT, STEPHEN WILLIAM
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 041098/0043 →
Assignment of Assignor's Interest Jan 26, 2017
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0038 →
Assignment of Assignor's Interest Jan 26, 2017
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0001 →
Notice of Grant of Security Interest in Intellectual Property Dec 22, 2017
From: OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044949/0634 →
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913 Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Assignment of Assignor's Interest Jan 31, 2024
From: OCERA THERAPEUTICS, INC.
To: OCERA THERAPEUTICS LLC
Reel/Frame 066403/0804 →
Release of Security Interest Oct 7, 2024
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 068810/0460 →
Assignment of Assignor's Interest Oct 25, 2024
From: OCERA THERAPEUTICS LLC
To: AMALIVE LIMITED
Reel/Frame 069017/0200 →
Release of Security Interest Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →